Future work will leverage these data to interrogate tumor immune and vascular microenvironment alterations induced by irradiation and Atm loss, which may guide the rational design of combinations of RT, ATM inhibitors, and therapies targeting the immune system or vasculature. This evidence concerns the gene ATM and neoplasm.